Cargando…

P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring

INTRODUCTION: Placental-Cadherin (CDH3) is a cell adhesion molecule vital to cellular localization and tissue integrity. It is highly expressed in the placenta (PLC)and is overexpressed by many types of cancer. P-cadherin levels in colorectal cancer (CRC) remains poorly characterized. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumara, H.M.C. Shantha, Bellini, Geoffrey A., Caballero, Otavia L., Herath, Sonali A.C., Su, Tao, Ahmed, Aqeel, Njoh, Linda, Cekic, Vesna, Whelan, Richard L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672898/ https://www.ncbi.nlm.nih.gov/pubmed/29142905 http://dx.doi.org/10.18632/oncoscience.370

Ejemplares similares

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy
por: Kumara, H.M.C. Shantha, et al.
Publicado: (2021)

Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection
por: Shantha Kumara, HMC, et al.
Publicado: (2019)

Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases
por: Shantha Kumara, HMC, et al.
Publicado: (2021)

Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection
por: Shantha Kumara, HMC, et al.
Publicado: (2023)

Sustained postoperative plasma elevations of plasminogen activator inhibitor-1 following minimally invasive colorectal cancer resection
por: Kumara, H.M.C. Shantha, et al.
Publicado: (2022)

Plasma Levels of Keratinocyte Growth Factor Are Significantly Elevated for 5 Weeks After Minimally Invasive Colorectal Resection Which May Promote Cancer Recurrence and Metastasis
por: Shantha Kumara, H. M. C., et al.
Publicado: (2021)

Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1 month after minimally invasive colorectal cancer resection
por: Shantha Kumara, H. M. C., et al.
Publicado: (2018)

Sclerotherapy needle injections can expand the subserosal and muscularis propria layers and cause a stable mucosal lift in ESD/EMR patients
por: Sandhu, Jaspreet, et al.
Publicado: (2018)

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia
por: Balan, Shabeesh, et al.
Publicado: (2021)

FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts
por: Black, Markaisa, et al.
Publicado: (2018)

3D Chromatin Architecture Re-Wiring at the CDH3/CDH1 Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer
por: São José, Celina, et al.
Publicado: (2023)

Human Blood Autoantibodies in the Detection of Colorectal Cancer
por: Negm, Ola H., et al.
Publicado: (2016)

Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma
por: Zhou, Xiaohui, et al.
Publicado: (2020)

Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
por: Ku, Su-Chi, et al.
Publicado: (2022)

CDH3/P-cadherin overexpression in breast carcinomas: its regulatory mechanisms, the role in cell invasion, and the association with cancer stem cell properties
por: Paredes, Joana
Publicado: (2010)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Down-Regulation of CDH1 Is Associated with Expression of SNAI1 in Colorectal Adenomas
por: Kroepil, Feride, et al.
Publicado: (2012)

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
por: Caldeira, José Roberto F, et al.
Publicado: (2006)

Role of the Adiponectin Binding Protein, T-Cadherin (Cdh13), in Allergic Airways Responses in Mice
por: Williams, Alison S., et al.
Publicado: (2012)

CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells
por: Baek, Sungmin, et al.
Publicado: (2010)

Role of the Adiponectin Binding Protein, T-Cadherin (cdh13), in Pulmonary Responses to Subacute Ozone
por: Kasahara, David I., et al.
Publicado: (2013)

Cadherin-26 (CDH26) regulates airway epithelial cell cytoskeletal structure and polarity
por: Lachowicz-Scroggins, Marrah E., et al.
Publicado: (2018)

E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations
por: Corso, Giovanni, et al.
Publicado: (2020)

Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia
por: Parker, Jessica, et al.
Publicado: (2023)

E-cadherin and Snail Immunoexpression in Colorectal Adenocarcinomas
por: AL KHATIB, AM, et al.
Publicado: (2019)

Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface
por: Karthikeyan, Subbulakshmi, et al.
Publicado: (2016)

AFF4 Predicts the Prognosis of Colorectal Cancer Patients and Suppresses Colorectal Cancer Metastasis via Promoting CDH1 Expression
por: Fang, Yi, et al.
Publicado: (2022)

CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management
por: Shenoy, Santosh
Publicado: (2019)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
por: Rajkumar, Sharmilla Devi, et al.
Publicado: (2021)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?
por: Karch, Inga, et al.
Publicado: (2013)

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis
por: Kim, Sun A, et al.
Publicado: (2016)

CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression
por: Xie, Jian, et al.
Publicado: (2016)

Flying under the radar: CDH2 (N-cadherin), an important hub molecule in neurodevelopmental and neurodegenerative diseases
por: László, Zsófia I., et al.
Publicado: (2022)

The Role of Cadherin 12 (CDH12) in the Peritoneal Fluid among Patients with Endometriosis and Endometriosis-Related Infertility
por: Goławski, Ksawery, et al.
Publicado: (2022)

Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2022)

Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo()
por: Kubelis-López, David Emmanuel, et al.
Publicado: (2023)

Mutations in the Spliceosome Component prp-6 and Overexpression of cdh-5 Suppress Axon Guidance Defects of cdh-4 Mutants in Caenorhabditis elegans
por: Aburegeba, Zina, et al.
Publicado: (2022)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u0uo2bfgomf92093o3e0sdg281